Cencora (COR) came out with quarterly earnings of $4.42 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.80 per share a year ago.

Techne (TECH) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.48 per share a year ago.

The European Union's health regulator said on Wednesday it has begun a review of Valneva's chikungunya vaccine after reports of serious adverse events in older adults, including two deaths globally.

Turning Point Brands (TPB) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.80 per share a year ago.

RXO (RXO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.03 per share a year ago.

The company aims to maximize Bitcoin exposure per share over the long run, including through novel financial strategies not previously used by other Bitcoin treasury companies, to maximize value accretion for common equity shareholders. Details available in slide presentation at Strive.com.

With all the talk about tariffs potentially causing the U.S. economy to slip into a recession, it's not surprising that small-cap stocks — a domestically focused asset class — are lower on a year-to-date basis. The average loss of 7.

Investors were eager to close the books on April's tariff-fueled market tantrum, which left both the Dow and S&P 500 riding three-month losing streaks despite a recent rebound. Equity ETF flows cooled, while fixed income ETFs put on a decisively skittish performance.

Gogo dealer network is pushing ahead with Supplemental Type Certificate (STC) generation. Gogo dealer network is pushing ahead with Supplemental Type Certificate (STC) generation.

ROCHESTER, NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced it is enabling optics for the clinical development of innovative, non-incisional optics-based refractive error correction to recover near vision. This common age-related vision condition, affecting an estimated 128 million people in the U.S. alone, presents a significant and growing market opportunity for effective treatment solutions.

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.34 per share a year ago.

RACINE, Wis. , May 7, 2025 /PRNewswire/ -- Modine (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that it will host a conference call and webcast to discuss its fourth quarter and fiscal year 2025 financial results for the period ended March 31, 2025, on Wednesday, May 21, 2025, at 10:00 a.m.

PHILADELPHIA , May 7, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Fluence Energy, Inc. ("Fluence" or the "Company") (NASDAQ: FLNC) on behalf of purchasers of Fluence securities between October 28, 2021 through February 10, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Fluence securities during the Class Period may, no later than MAY 12, 2025 , seek to be appointed as a lead plaintiff representative of the class.

According to CrowdStrike's CEO, the company's pivot to AI would allow it to “move faster” and “operate more efficiently.”

ORLANDO, Fla. , May 7, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced its subsidiary G5 Infrared ("G5"), a leading high-end infrared camera systems manufacturer, received a $4.9 million follow-on order from an existing defense industry customer, for delivery in the Company's 2026 fiscal year.

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has declared a 1-for-25 reverse stock split of the company's common stock, which will be effective for trading purposes upon the commencement of trading on May 9, 2025.

Sales from VRTX's new drugs, Casgevy, Alyftrek and Journavx, in Q1 fell short of investor expectations.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=147289&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=147269&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=147270&wire=1 or contact Joseph E. Levi, Esq.